메뉴 건너뛰기




Volumn 5, Issue 6, 2016, Pages e336-

Erratum: Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates (Molecular Therapy - Nucleic Acids (2016) 5 (S2162253117300513), (10.1038/mtna.2016.36));Pharmacokinetics and pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in mice and non-human primates

Author keywords

Cynomolgus monkeys; LNA inhibitor; MicroRNA; MiRNA therapeutics; Multiple myeloma

Indexed keywords

13 MER LOCKED NUCLEIC ACID MICRORNA 221; ANTINEOPLASTIC AGENT; LOCKED NUCLEIC ACID; MICRORNA 221; PROTEIN P27; UNCLASSIFIED DRUG;

EID: 85007463568     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2016.59     Document Type: Erratum
Times cited : (56)

References (53)
  • 1
    • 84879592480 scopus 로고    scopus 로고
    • Non-coding RNA: A novel opportunity for the personalized treatment of multiple myeloma
    • Amodio, N, Di Martino, MT, Neri, A, Tagliaferri, P and Tassone, P (2013). Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma. Expert Opin Biol Ther 13 (SUPPL. 1): S125-S137.
    • (2013) Expert Opin Biol Ther , vol.13 , pp. S125-S137
    • Amodio, N.1    Di Martino, M.T.2    Neri, A.3    Tagliaferri, P.4    Tassone, P.5
  • 2
    • 81355142141 scopus 로고    scopus 로고
    • Non-coding RNAs in human disease
    • Esteller, M (2011). Non-coding RNAs in human disease. Nat Rev Genet 12: 861-874.
    • (2011) Nat Rev Genet , vol.12 , pp. 861-874
    • Esteller, M.1
  • 3
    • 12144290519 scopus 로고    scopus 로고
    • Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
    • Calin, GA, Sevignani, C, Dumitru, CD, Hyslop, T, Noch, E, Yendamuri, S et al. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004.
    • (2004) Proc Natl Acad Sci USA , vol.101 , pp. 2999-3004
    • Calin, G.A.1    Sevignani, C.2    Dumitru, C.D.3    Hyslop, T.4    Noch, E.5    Yendamuri, S.6
  • 4
    • 84928715671 scopus 로고    scopus 로고
    • The microRNA feedback regulation of p63 in cancer progression
    • Lin, C, Li, X, Zhang, Y, Guo, Y, Zhou, J, Gao, K et al. (2015). The microRNA feedback regulation of p63 in cancer progression. Oncotarget 6: 8434-8453.
    • (2015) Oncotarget , vol.6 , pp. 8434-8453
    • Lin, C.1    Li, X.2    Zhang, Y.3    Guo, Y.4    Zhou, J.5    Gao, K.6
  • 5
    • 84938885920 scopus 로고    scopus 로고
    • Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma
    • Di Martino, MT, Guzzi, PH, Caracciolo, D, Agnelli, L, Neri, A, Walker, BA et al. (2015). Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma. Oncotarget 6: 19132-19147.
    • (2015) Oncotarget , vol.6 , pp. 19132-19147
    • Di Martino, M.T.1    Guzzi, P.H.2    Caracciolo, D.3    Agnelli, L.4    Neri, A.5    Walker, B.A.6
  • 6
    • 84879476643 scopus 로고    scopus 로고
    • Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia
    • Lionetti, M, Musto, P, Di Martino, MT, Fabris, S, Agnelli, L, Todoerti, K et al. (2013). Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia. Clin Cancer Res 19: 3130-3142.
    • (2013) Clin Cancer Res , vol.19 , pp. 3130-3142
    • Lionetti, M.1    Musto, P.2    Di Martino, M.T.3    Fabris, S.4    Agnelli, L.5    Todoerti, K.6
  • 8
    • 84931088607 scopus 로고    scopus 로고
    • miR-29s: A family of epi-miRNAs with therapeutic implications in hematologic Malignancies
    • Amodio, N, Rossi, M, Raimondi, L, Pitari, MR, Botta, C, Tagliaferri, P et al. (2015). miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies. Oncotarget 6: 12837-12861.
    • (2015) Oncotarget , vol.6 , pp. 12837-12861
    • Amodio, N.1    Rossi, M.2    Raimondi, L.3    Pitari, M.R.4    Botta, C.5    Tagliaferri, P.6
  • 9
    • 84881349597 scopus 로고    scopus 로고
    • From target therapy to miRNA therapeutics of human multiple myeloma: Theoretical and technological issues in the evolving scenario
    • Rossi, M, Amodio, N, Di Martino, MT, Caracciolo, D, Tagliaferri, P and Tassone, P (2013). From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario. Curr Drug Targets 14: 1144-1149.
    • (2013) Curr Drug Targets , vol.14 , pp. 1144-1149
    • Rossi, M.1    Amodio, N.2    Di Martino, M.T.3    Caracciolo, D.4    Tagliaferri, P.5    Tassone, P.6
  • 11
    • 84890290469 scopus 로고    scopus 로고
    • miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells
    • Amodio, N, Bellizzi, D, Leotta, M, Raimondi, L, Biamonte, L, D'Aquila, P et al. (2013). miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells. Cell Cycle 12: 3650-3662.
    • (2013) Cell Cycle , vol.12 , pp. 3650-3662
    • Amodio, N.1    Bellizzi, D.2    Leotta, M.3    Raimondi, L.4    Biamonte, L.5    D'Aquila, P.6
  • 12
    • 84896119502 scopus 로고    scopus 로고
    • In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells
    • Di Martino, MT, Gullà, A, Gallo Cantafio, ME, Altomare, E, Amodio, N, Leone, E et al. (2014). In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells. PLoS One 9: e89659.
    • (2014) PLoS One , vol.9
    • Di Martino, M.T.1    Gullà, A.2    Gallo Cantafio, M.E.3    Altomare, E.4    Amodio, N.5    Leone, E.6
  • 13
    • 84902085012 scopus 로고    scopus 로고
    • Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity
    • Raimondi, L, Amodio, N, Di Martino, MT, Altomare, E, Leotta, M, Caracciolo, D et al. (2014). Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity. Oncotarget 5: 3039-3054.
    • (2014) Oncotarget , vol.5 , pp. 3039-3054
    • Raimondi, L.1    Amodio, N.2    Di Martino, M.T.3    Altomare, E.4    Leotta, M.5    Caracciolo, D.6
  • 15
    • 84906691556 scopus 로고    scopus 로고
    • A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells
    • Leotta, M, Biamonte, L, Raimondi, L, Ronchetti, D, Di Martino, MT, Botta, C et al. (2014). A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells. J Cell Physiol 229: 2106-2116.
    • (2014) J Cell Physiol , vol.229 , pp. 2106-2116
    • Leotta, M.1    Biamonte, L.2    Raimondi, L.3    Ronchetti, D.4    Di Martino, M.T.5    Botta, C.6
  • 17
    • 84896134590 scopus 로고    scopus 로고
    • Transferrin-conjugated SNALPs encapsulating 2'-O-methylated miR-34a for the treatment of multiple myeloma
    • Scognamiglio, I, Di Martino, MT, Campani, V, Virgilio, A, Galeone, A, Gullà, A et al. (2014). Transferrin-conjugated SNALPs encapsulating 2'-O-methylated miR-34a for the treatment of multiple myeloma. Biomed Res Int 2014: 217-365.
    • (2014) Biomed Res Int , vol.2014 , pp. 217-365
    • Scognamiglio, I.1    Di Martino, M.T.2    Campani, V.3    Virgilio, A.4    Galeone, A.5    Gullà, A.6
  • 18
    • 84871694384 scopus 로고    scopus 로고
    • DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
    • Amodio, N, Leotta, M, Bellizzi, D, Di Martino, MT, D'Aquila, P, Lionetti, M et al. (2012). DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma. Oncotarget 3: 1246-1258.
    • (2012) Oncotarget , vol.3 , pp. 1246-1258
    • Amodio, N.1    Leotta, M.2    Bellizzi, D.3    Di Martino, M.T.4    D'Aquila, P.5    Lionetti, M.6
  • 19
    • 84897872063 scopus 로고    scopus 로고
    • In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma
    • Di Martino, MT, Campani, V, Misso, G, Gallo Cantafio, ME, Gullà, A, Foresta, U et al. (2014). In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma. PLoS One 9: e90005.
    • (2014) PLoS One , vol.9
    • Di Martino, M.T.1    Campani, V.2    Misso, G.3    Gallo Cantafio, M.E.4    Gullà, A.5    Foresta, U.6
  • 20
    • 84875766140 scopus 로고    scopus 로고
    • In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma
    • Di Martino, MT, Gullà, A, Cantafio, ME, Lionetti, M, Leone, E, Amodio, N et al. (2013). In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma. Oncotarget 4: 242-255.
    • (2013) Oncotarget , vol.4 , pp. 242-255
    • Di Martino, M.T.1    Gullà, A.2    Cantafio, M.E.3    Lionetti, M.4    Leone, E.5    Amodio, N.6
  • 21
    • 84866434864 scopus 로고    scopus 로고
    • Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma
    • Tassone, P, Neri, P, Burger, R, Di Martino, MT, Leone, E, Amodio, N et al. (2012). Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma. Curr Cancer Drug Targets 12: 814-822.
    • (2012) Curr Cancer Drug Targets , vol.12 , pp. 814-822
    • Tassone, P.1    Neri, P.2    Burger, R.3    Di Martino, M.T.4    Leone, E.5    Amodio, N.6
  • 22
    • 84869219338 scopus 로고    scopus 로고
    • miR-34 - A microRNA replacement therapy is headed to the clinic
    • Bader, AG (2012). miR-34 - a microRNA replacement therapy is headed to the clinic. Front Genet 3: 120.
    • (2012) Front Genet , vol.3 , pp. 120
    • Bader, A.G.1
  • 23
    • 84870543762 scopus 로고    scopus 로고
    • miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor sp1
    • Amodio, N, Di Martino, MT, Foresta, U, Leone, E, Lionetti, M, Leotta, M et al. (2012). miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. Cell Death Dis 3: e436.
    • (2012) Cell Death Dis , vol.3 , pp. e436
    • Amodio, N.1    Di Martino, M.T.2    Foresta, U.3    Leone, E.4    Lionetti, M.5    Leotta, M.6
  • 24
    • 84869238270 scopus 로고    scopus 로고
    • Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: In vitro and in vivo evidence
    • Di Martino, MT, Leone, E, Amodio, N, Foresta, U, Lionetti, M, Pitari, MR et al. (2012). Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: In vitro and in vivo evidence. Clin Cancer Res 18: 6260-6270.
    • (2012) Clin Cancer Res , vol.18 , pp. 6260-6270
    • Di Martino, M.T.1    Leone, E.2    Amodio, N.3    Foresta, U.4    Lionetti, M.5    Pitari, M.R.6
  • 25
    • 84946494986 scopus 로고    scopus 로고
    • Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
    • Morelli, E, Leone, E, Cantafio, ME, Di Martino, MT, Amodio, N, Biamonte, L et al. (2015). Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo. Leukemia 29: 2173-2183.
    • (2015) Leukemia , vol.29 , pp. 2173-2183
    • Morelli, E.1    Leone, E.2    Cantafio, M.E.3    Di Martino, M.T.4    Amodio, N.5    Biamonte, L.6
  • 26
    • 84931044088 scopus 로고    scopus 로고
    • miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1)
    • Han, Z, Zhang, Y, Yang, Q, Liu, B, Wu, J, Zhang, Y et al. (2015). miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1). Oncotarget 6: 13149-13163.
    • (2015) Oncotarget , vol.6 , pp. 13149-13163
    • Han, Z.1    Zhang, Y.2    Yang, Q.3    Liu, B.4    Wu, J.5    Zhang, Y.6
  • 27
    • 84940890937 scopus 로고    scopus 로고
    • Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-myc
    • Liu, Y, Li, X, Zhu, S, Zhang, JG, Yang, M, Qin, Q et al. (2015). Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc. Gene Ther 22: 729-738.
    • (2015) Gene Ther , vol.22 , pp. 729-738
    • Liu, Y.1    Li, X.2    Zhu, S.3    Zhang, J.G.4    Yang, M.5    Qin, Q.6
  • 28
    • 84938149957 scopus 로고    scopus 로고
    • Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells
    • Tréhoux, S, Lahdaoui, F, Delpu, Y, Renaud, F, Leteurtre, E, Torrisani, J et al. (2015). Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells. Biochim Biophys Acta 1853(10 Pt A): 2392-2403.
    • (2015) Biochim Biophys Acta , vol.1853 , Issue.10 , pp. 2392-2403
    • Tréhoux, S.1    Lahdaoui, F.2    Delpu, Y.3    Renaud, F.4    Leteurtre, E.5    Torrisani, J.6
  • 29
    • 84991922343 scopus 로고    scopus 로고
    • Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets
    • Zheng, F, Liao, YJ, Cai, MY, Liu, TH, Chen, SP, Wu, PH et al. (2015). Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets. PLoS Genet 11: e1004873.
    • (2015) PLoS Genet , vol.11
    • Zheng, F.1    Liao, Y.J.2    Cai, M.Y.3    Liu, T.H.4    Chen, S.P.5    Wu, P.H.6
  • 30
    • 84885113592 scopus 로고    scopus 로고
    • Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy
    • Guzman-Aranguez, A, Loma, P and Pintor, J (2013). Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy. Br J Pharmacol 170: 730-747.
    • (2013) Br J Pharmacol , vol.170 , pp. 730-747
    • Guzman-Aranguez, A.1    Loma, P.2    Pintor, J.3
  • 31
    • 84987630012 scopus 로고    scopus 로고
    • Therapeutic antisense oligonucleotides against cancer: Hurdling to the clinic
    • Moreno, PM and Pêgo, AP (2014). Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic. Front Chem 2: 87.
    • (2014) Front Chem , vol.2 , pp. 87
    • Moreno, P.M.1    Pêgo, A.P.2
  • 33
    • 84872432062 scopus 로고    scopus 로고
    • Clinical pharmacokinetics of second generation antisense oligonucleotides
    • Yu, RZ, Grundy, JS and Geary, RS (2013). Clinical pharmacokinetics of second generation antisense oligonucleotides. Expert Opin Drug Metab Toxicol 9: 169-182.
    • (2013) Expert Opin Drug Metab Toxicol , vol.9 , pp. 169-182
    • Yu, R.Z.1    Grundy, J.S.2    Geary, R.S.3
  • 35
    • 78649877710 scopus 로고    scopus 로고
    • Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates
    • Straarup, EM, Fisker, N, Hedtjärn, M, Lindholm, MW, Rosenbohm, C, Aarup, V et al. (2010). Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates. Nucleic Acids Res 38: 7100-7111.
    • (2010) Nucleic Acids Res , vol.38 , pp. 7100-7111
    • Straarup, E.M.1    Fisker, N.2    Hedtjärn, M.3    Lindholm, M.W.4    Rosenbohm, C.5    Aarup, V.6
  • 36
    • 74249112787 scopus 로고    scopus 로고
    • Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
    • Lanford, RE, Hildebrandt-Eriksen, ES, Petri, A, Persson, R, Lindow, M, Munk, ME et al. (2010). Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327: 198-201.
    • (2010) Science , vol.327 , pp. 198-201
    • Lanford, R.E.1    Hildebrandt-Eriksen, E.S.2    Petri, A.3    Persson, R.4    Lindow, M.5    Munk, M.E.6
  • 39
    • 84887841103 scopus 로고    scopus 로고
    • First-in-human phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer
    • Bianchini, D, Omlin, A, Pezaro, C, Lorente, D, Ferraldeschi, R, Mukherji, D et al. (2013). First-in-human phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer. Br J Cancer 109: 2579-2586.
    • (2013) Br J Cancer , vol.109 , pp. 2579-2586
    • Bianchini, D.1    Omlin, A.2    Pezaro, C.3    Lorente, D.4    Ferraldeschi, R.5    Mukherji, D.6
  • 41
    • 79953075257 scopus 로고    scopus 로고
    • Bioanalytical LC-MS of therapeutic oligonucleotides
    • van Dongen, WD and Niessen, WM (2011). Bioanalytical LC-MS of therapeutic oligonucleotides. Bioanalysis 3: 541-564.
    • (2011) Bioanalysis , vol.3 , pp. 541-564
    • Van Dongen, W.D.1    Niessen, W.M.2
  • 42
    • 33847338002 scopus 로고    scopus 로고
    • Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100
    • Yu, RZ, Kim, TW, Hong, A, Watanabe, TA, Gaus, HJ and Geary, RS (2007). Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100. Drug Metab Dispos 35: 460-468.
    • (2007) Drug Metab Dispos , vol.35 , pp. 460-468
    • Yu, R.Z.1    Kim, T.W.2    Hong, A.3    Watanabe, T.A.4    Gaus, H.J.5    Geary, R.S.6
  • 43
    • 79959479529 scopus 로고    scopus 로고
    • Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes
    • Koller, E, Vincent, TM, Chappell, A, De, S, Manoharan, M and Bennett, CF (2011). Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes. Nucleic Acids Res 39: 4795-4807.
    • (2011) Nucleic Acids Res , vol.39 , pp. 4795-4807
    • Koller, E.1    Vincent, T.M.2    Chappell, A.3    De, S.4    Manoharan, M.5    Bennett, C.F.6
  • 44
    • 0035043324 scopus 로고    scopus 로고
    • Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides
    • Geary, RS, Yu, RZ and Levin, AA (2001). Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides. Curr Opin Investig Drugs 2: 562-573.
    • (2001) Curr Opin Investig Drugs , vol.2 , pp. 562-573
    • Geary, R.S.1    Yu, R.Z.2    Levin, A.A.3
  • 45
    • 84858020530 scopus 로고    scopus 로고
    • Peripheral administration of antisense oligonucleotides targeting the amyloid-β protein precursor reverses AβPP and LRP-1 overexpression in the aged SAMP8 mouse brain
    • Erickson, MA, Niehoff, ML, Farr, SA, Morley, JE, Dillman, LA, Lynch, KM et al. (2012). Peripheral administration of antisense oligonucleotides targeting the amyloid-β protein precursor reverses AβPP and LRP-1 overexpression in the aged SAMP8 mouse brain. J Alzheimers Dis 28: 951-960.
    • (2012) J Alzheimers Dis , vol.28 , pp. 951-960
    • Erickson, M.A.1    Niehoff, M.L.2    Farr, S.A.3    Morley, J.E.4    Dillman, L.A.5    Lynch, K.M.6
  • 46
    • 80054760122 scopus 로고    scopus 로고
    • Measurement of phosphorothioate oligodeoxynucleotide antisense transport across the blood-brain barrier
    • Banks, WA (2011). Measurement of phosphorothioate oligodeoxynucleotide antisense transport across the blood-brain barrier. Methods Mol Biol 789: 337-342.
    • (2011) Methods Mol Biol , vol.789 , pp. 337-342
    • Banks, W.A.1
  • 47
    • 0035015218 scopus 로고    scopus 로고
    • Delivery across the blood-brain barrier of antisense directed against amyloid beta: Reversal of learning and memory deficits in mice overexpressing amyloid precursor protein
    • Banks, WA, Farr, SA, Butt, W, Kumar, VB, Franko, MW and Morley, JE (2001). Delivery across the blood-brain barrier of antisense directed against amyloid beta: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein. J Pharmacol Exp Ther 297: 1113-1121.
    • (2001) J Pharmacol Exp Ther , vol.297 , pp. 1113-1121
    • Banks, W.A.1    Farr, S.A.2    Butt, W.3    Kumar, V.B.4    Franko, M.W.5    Morley, J.E.6
  • 48
    • 84937252483 scopus 로고    scopus 로고
    • Antisense oligonucleotides in therapy for neurodegenerative disorders
    • Evers, MM, Toonen, LJ and van Roon-Mom, WM (2015). Antisense oligonucleotides in therapy for neurodegenerative disorders. Adv Drug Deliv Rev 87: 90-103.
    • (2015) Adv Drug Deliv Rev , vol.87 , pp. 90-103
    • Evers, M.M.1    Toonen, L.J.2    Van Roon-Mom, W.M.3
  • 49
    • 0028241377 scopus 로고
    • Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate
    • Sands, H, Gorey-Feret, LJ, Cocuzza, AJ, Hobbs, FW, Chidester, D and Trainor, GL (1994). Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate. Mol Pharmacol 45: 932-943.
    • (1994) Mol Pharmacol , vol.45 , pp. 932-943
    • Sands, H.1    Gorey-Feret, L.J.2    Cocuzza, A.J.3    Hobbs, F.W.4    Chidester, D.5    Trainor, G.L.6
  • 50
    • 84856431819 scopus 로고    scopus 로고
    • RNA therapeutics: Beyond RNA interference and antisense oligonucleotides
    • Kole, R, Krainer, AR and Altman, S (2012). RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov 11: 125-140.
    • (2012) Nat Rev Drug Discov , vol.11 , pp. 125-140
    • Kole, R.1    Krainer, A.R.2    Altman, S.3
  • 51
    • 78349312100 scopus 로고    scopus 로고
    • Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes
    • Jørgensen, S, Baker, A, Møller, S and Nielsen, BS (2010). Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 52: 375-381.
    • (2010) Methods , vol.52 , pp. 375-381
    • Jørgensen, S.1    Baker, A.2    Møller, S.3    Nielsen, B.S.4
  • 52
    • 79951671912 scopus 로고    scopus 로고
    • High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients
    • Nielsen, BS, Jørgensen, S, Fog, JU, Søkilde, R, Christensen, IJ, Hansen, U et al. (2011). High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 28: 27-38.
    • (2011) Clin Exp Metastasis , vol.28 , pp. 27-38
    • Nielsen, B.S.1    Jørgensen, S.2    Fog, J.U.3    Søkilde, R.4    Christensen, I.J.5    Hansen, U.6
  • 53
    • 84921825723 scopus 로고    scopus 로고
    • Chromogen detection of microRNA in frozen clinical tissue samples using LNA" probe technology
    • Nielsen, BS, Møller, T and Holmstrøm, K (2014). Chromogen detection of microRNA in frozen clinical tissue samples using LNA" probe technology. Methods Mol Biol 1211: 77-84.
    • (2014) Methods Mol Biol , vol.1211 , pp. 77-84
    • Nielsen, B.S.1    Møller, T.2    Holmstrøm, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.